The culprit behind the recalls is ‘shiga-toxin-producing E. coli’. What do you need to know about this bacterium?
BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious life-threatening infections caused by ...